BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 30940706)

  • 1. Mutations in
    Rybak JM; Ge W; Wiederhold NP; Parker JE; Kelly SL; Rogers PD; Fortwendel JR
    mBio; 2019 Apr; 10(2):. PubMed ID: 30940706
    [No Abstract]   [Full Text] [Related]  

  • 2. A secondary mechanism of action for triazole antifungals in Aspergillus fumigatus mediated by hmg1.
    Rybak JM; Xie J; Martin-Vicente A; Guruceaga X; Thorn HI; Nywening AV; Ge W; Souza ACO; Shetty AC; McCracken C; Bruno VM; Parker JE; Kelly SL; Snell HM; Cuomo CA; Rogers PD; Fortwendel JR
    Nat Commun; 2024 Apr; 15(1):3642. PubMed ID: 38684680
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Souza ACO; Ge W; Wiederhold NP; Rybak JM; Fortwendel JR; Rogers PD
    Microbiol Spectr; 2023 Jun; 11(3):e0518822. PubMed ID: 37140376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are Point Mutations in HMG-CoA Reductases (Hmg1 and Hmg2) a Step towards Azole Resistance in
    Gonzalez-Jimenez I; Lucio J; Roldan A; Alcazar-Fuoli L; Mellado E
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-cyp51A Azole-Resistant Aspergillus fumigatus Isolates with Mutation in HMG-CoA Reductase.
    Hagiwara D; Arai T; Takahashi H; Kusuya Y; Watanabe A; Kamei K
    Emerg Infect Dis; 2018 Oct; 24(10):1889-1897. PubMed ID: 30226177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging threat of triazole-resistant Aspergillus fumigatus.
    Rybak JM; Fortwendel JR; Rogers PD
    J Antimicrob Chemother; 2019 Apr; 74(4):835-842. PubMed ID: 30561652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triazole-Resistant Aspergillus fumigatus in an Israeli Patient with Chronic Cavitary Pulmonary Aspergillosis Due to a Novel E306K Substitution in Hmg1.
    Handelman M; Morogovsky A; Liu W; Ben-Ami R; Osherov N
    Antimicrob Agents Chemother; 2021 Sep; 65(10):e0108921. PubMed ID: 34280014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hmg1 mutations in Aspergillus fumigatus and their contribution to triazole susceptibility.
    Arai T; Umeyama T; Majima H; Inukai T; Watanabe A; Miyazaki Y; Kamei K
    Med Mycol; 2021 Oct; 59(10):980-984. PubMed ID: 34019670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of W272C Substitution in Hmg1 in a Triazole-Resistant Isolate of Aspergillus fumigatus from a Chinese Patient with Chronic Cavitary Pulmonary Aspergillosis.
    Liang T; Yang X; Li R; Yang E; Wang Q; Osherov N; Chen W; Wan Z; Liu W
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0026321. PubMed ID: 33941517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic perspective of triazole resistance in clinical and environmental Aspergillus fumigatus isolates without cyp51A mutations.
    Sharma C; Nelson-Sathi S; Singh A; Radhakrishna Pillai M; Chowdhary A
    Fungal Genet Biol; 2019 Nov; 132():103265. PubMed ID: 31465846
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Resendiz-Sharpe A; Hokken MWJ; Mercier T; Merckx R; Verhagen K; Dewitte L; Melchers WJG; Verweij PE; Maertens J; Lagrou K
    J Fungi (Basel); 2020 Oct; 6(4):. PubMed ID: 33081232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of triazole resistance in clinical Aspergillus fumigatus isolates in a specialist cardiothoracic centre.
    Abdolrasouli A; Scourfield A; Rhodes J; Shah A; Elborn JS; Fisher MC; Schelenz S; Armstrong-James D
    Int J Antimicrob Agents; 2018 Nov; 52(5):637-642. PubMed ID: 30103005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-triazole-resistant Aspergillus fumigatus infections in Australia.
    Kidd SE; Goeman E; Meis JF; Slavin MA; Verweij PE
    Mycoses; 2015 Jun; 58(6):350-5. PubMed ID: 25885568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triazole phenotypes and genotypic characterization of clinical Aspergillus fumigatus isolates in China.
    Deng S; Zhang L; Ji Y; Verweij PE; Tsui KM; Hagen F; Houbraken J; Meis JF; Abliz P; Wang X; Zhao J; Liao W
    Emerg Microbes Infect; 2017 Dec; 6(12):e109. PubMed ID: 29209054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Polish clinical Aspergillus fumigatus isolates resistant to triazoles.
    Nawrot U; Kurzyk E; Arendrup MC; Mroczynska M; Wlodarczyk K; Sulik-Tyszka B; Wróblewska M; Ussowicz M; Zdziarski P; Niewinska K; Brillowska-Dabrowska A
    Med Mycol; 2018 Jan; 56(1):121-124. PubMed ID: 28340159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SREBP-dependent triazole susceptibility in Aspergillus fumigatus is mediated through direct transcriptional regulation of erg11A (cyp51A).
    Blosser SJ; Cramer RA
    Antimicrob Agents Chemother; 2012 Jan; 56(1):248-57. PubMed ID: 22006005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Broad Allele-Specific TaqMan Real-Time PCR Method To Detect Triazole-Resistant Strains of Aspergillus fumigatus, Even with a Very Low Percentage of Triazole-Resistant Cells Mixed with Triazole-Susceptible Cells.
    Wang Q; Kontoyiannis DP; Li R; Chen W; Bu D; Liu W
    J Clin Microbiol; 2019 Sep; 57(9):. PubMed ID: 31315952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India.
    Chowdhary A; Kathuria S; Randhawa HS; Gaur SN; Klaassen CH; Meis JF
    J Antimicrob Chemother; 2012 Feb; 67(2):362-6. PubMed ID: 22028200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point Mutation or Overexpression of Aspergillus fumigatus
    Handelman M; Meir Z; Scott J; Shadkchan Y; Liu W; Ben-Ami R; Amich J; Osherov N
    Antimicrob Agents Chemother; 2021 Sep; 65(10):e0125221. PubMed ID: 34310208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triazole resistance in Aspergillus fumigatus: recent insights and challenges for patient management.
    Lestrade PPA; Meis JF; Melchers WJG; Verweij PE
    Clin Microbiol Infect; 2019 Jul; 25(7):799-806. PubMed ID: 30580035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.